Azidoblebbistatin is a novel photoreactive myosin inhibitor that allows irreversible crosslinking to myosin II, providing a highly effective tool for structural and functional studies of actomyosin contractility.
No takes yet. Share an insight, caveat, or question.
May advance actomyosin research tools via irreversible inhibition; leaves open validation in mammalian models.
Képiró et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: